Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses

Detalhes bibliográficos
Autor(a) principal: Magalhães, Pablo C.
Data de Publicação: 2011
Outros Autores: Benjamin, Laércio dos A., Oliveira, Aécio C. de, Pinto, José de O., Zandim, Bruna M., Souza, Maria V. de, Maia, Leandro, Ribeiro Júnior, José I.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: LOCUS Repositório Institucional da UFV
Texto Completo: http://dx.doi.org/10.1590/S0100-736X2012000100014
http://www.locus.ufv.br/handle/123456789/18225
Resumo: This study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15 ±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissue
id UFV_8b89575d9fce195f68eed20deb8f969f
oai_identifier_str oai:locus.ufv.br:123456789/18225
network_acronym_str UFV
network_name_str LOCUS Repositório Institucional da UFV
repository_id_str 2145
spelling Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horsesPlasma rich in plateletsPlatelet functionGrowth factorsHorsesThis study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15 ±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissueO objetivo desse estudo foi investigar a capacidade de ativação do plasma rico em plaquetas (PRP) por substâncias farmacológicas, assim como verificar a necessidade ou não dessa ativação para uso terapêutico. O PRP foi obtido de quatro equinos mestiços hígidos, machos castrados, com 13 a 16 anos (15 ±1anos) de idade, e processado para observação e quantificação da morfologia plaquetária mediante a utilização da microscopia eletrônica de transmissão. Todas as amostras de PRP foram ativadas com cloreto de cálcio (CaCl2) a 10%, trombina bovina pura ou associada a CaCl2. O controle (PRP puro) não foi ativado farmacologicamente. Nas amostras de PRP puro, 49% das plaquetas foram classificadas como ativação incerta, 41% em repouso, 9% totalmente ativada e 1% com dano irreversível. O tratamento com CaCl2 a 10% proporcionou uma distribuição de 54% de plaquetas com ativação incerta, 24% totalmente ativada, 20% em repouso, e 2% como com dano irreversível. Amostras tratadas com trombina bovina apresentaram morfologia plaquetária que não se enquadraram na classificação adotada, apresentando forma irregular com emissão de grandes pseudópodes filamentosos, aspecto de rompimento e grânulos inteiros no citoplasma remanescente e meio extracelular. Houve efeito do tratamento sobre a morfologia plaquetária (P=0,03). O CaCl2 a 10% é um adequado agente ativador de plaquetas. Entretanto, nos casos onde se faz necessário o uso de PRP na forma mais líquida, recomenda-se o uso do PRP puro, que além de apresentar uma adequada porcentagem de plaquetas totalmente ativadas, também possui importante quantidade do tipo em repouso, que pode ser ativado por substâncias presentes no tecido lesionado.Pesquisa Veterinária Brasileira2018-03-13T17:52:02Z2018-03-13T17:52:02Z2011-10-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlepdfapplication/pdf1678-5150http://dx.doi.org/10.1590/S0100-736X2012000100014http://www.locus.ufv.br/handle/123456789/18225engv. 32, n. 1, p. 83-92, janeiro 2012Magalhães, Pablo C.Benjamin, Laércio dos A.Oliveira, Aécio C. dePinto, José de O.Zandim, Bruna M.Souza, Maria V. deMaia, LeandroRibeiro Júnior, José I.info:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFV2024-07-12T07:05:09Zoai:locus.ufv.br:123456789/18225Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452024-07-12T07:05:09LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false
dc.title.none.fl_str_mv Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
spellingShingle Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
Magalhães, Pablo C.
Plasma rich in platelets
Platelet function
Growth factors
Horses
title_short Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_full Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_fullStr Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_full_unstemmed Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
title_sort Platelet activation: ultrastructure and morphometry in platelet-rich plasma of horses
author Magalhães, Pablo C.
author_facet Magalhães, Pablo C.
Benjamin, Laércio dos A.
Oliveira, Aécio C. de
Pinto, José de O.
Zandim, Bruna M.
Souza, Maria V. de
Maia, Leandro
Ribeiro Júnior, José I.
author_role author
author2 Benjamin, Laércio dos A.
Oliveira, Aécio C. de
Pinto, José de O.
Zandim, Bruna M.
Souza, Maria V. de
Maia, Leandro
Ribeiro Júnior, José I.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Magalhães, Pablo C.
Benjamin, Laércio dos A.
Oliveira, Aécio C. de
Pinto, José de O.
Zandim, Bruna M.
Souza, Maria V. de
Maia, Leandro
Ribeiro Júnior, José I.
dc.subject.por.fl_str_mv Plasma rich in platelets
Platelet function
Growth factors
Horses
topic Plasma rich in platelets
Platelet function
Growth factors
Horses
description This study was conducted to investigate the activation ability of the platelet-rich plasma (PRP) by pharmacological agents, as well as to verify the need or not of this activation for therapeutic use. The PRP was obtained from four healthy crossbred geldings aged 13 to 16 years (15 ±1years), and was processed for observation and quantification of the platelet morphology by using the transmission electron microscopy. All PRP samples were activated with 10% calcium chloride (CaCl2) solution, pure bovine thrombin or associated with CaCl2. The control (pure PRP) was not pharmacologically activated. In the pure PRP samples, 49% of the platelets were classified as state of activation uncertain, 41% as resting, 9% as fully activated and 1% as irreversibly damaged. Treatment with 10% CaCl2 provided a distribution of 54% platelets in state of activation uncertain, 24% as fully activated, 20% as resting, and 2% as irreversibly damaged. The platelet morphology of the bovine thrombin treated samples did not fit into classification adopted, as showing irregular shape with emission of large filamentous pseudopods, appearance of ruptured and whole granules in the remaining cytoplasm and extracellular environment. There was effect of the treatment on the platelet morphology (P=0.03). The 10% CaCl2 is an adequate platelet-activating agent. However, in cases the use of PRP under its liquid form is necessary, the use of pure PRP is recommended, since besides presenting an adequate percentage of fully activated platelets it also has significant amount of the resting type, which can be activated by substances found in the injured tissue
publishDate 2011
dc.date.none.fl_str_mv 2011-10-24
2018-03-13T17:52:02Z
2018-03-13T17:52:02Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv 1678-5150
http://dx.doi.org/10.1590/S0100-736X2012000100014
http://www.locus.ufv.br/handle/123456789/18225
identifier_str_mv 1678-5150
url http://dx.doi.org/10.1590/S0100-736X2012000100014
http://www.locus.ufv.br/handle/123456789/18225
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv v. 32, n. 1, p. 83-92, janeiro 2012
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv pdf
application/pdf
dc.publisher.none.fl_str_mv Pesquisa Veterinária Brasileira
publisher.none.fl_str_mv Pesquisa Veterinária Brasileira
dc.source.none.fl_str_mv reponame:LOCUS Repositório Institucional da UFV
instname:Universidade Federal de Viçosa (UFV)
instacron:UFV
instname_str Universidade Federal de Viçosa (UFV)
instacron_str UFV
institution UFV
reponame_str LOCUS Repositório Institucional da UFV
collection LOCUS Repositório Institucional da UFV
repository.name.fl_str_mv LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)
repository.mail.fl_str_mv fabiojreis@ufv.br
_version_ 1822610602045997056